CRISPR: Established Editor of Human Embryos?
- PMID: 28886363
- PMCID: PMC5819596
- DOI: 10.1016/j.stem.2017.08.007
CRISPR: Established Editor of Human Embryos?
Abstract
Off-target effects and mosaicism are major concerns for applying CRISPR-Cas9 to correct genetic mutations. A recent article in Nature by Ma et al. (2017) uses an elegant CRISPR-Cas9 approach that repairs a genetic mutation in human embryos with negligible mosaicism and no off-target effects, bringing this editing tool closer to clinical application.
Copyright © 2017 Elsevier Inc. All rights reserved.
Comment on
-
Correction of a pathogenic gene mutation in human embryos.Nature. 2017 Aug 24;548(7668):413-419. doi: 10.1038/nature23305. Epub 2017 Aug 2. Nature. 2017. PMID: 28783728
References
-
- Ma H, Marti-Gutierrez N, Park SW, Wu J, Lee Y, Suzuki K, Koski A, Ji D, Hayama T, Ahmed R, et al. Nature. 2017;2 in press Published online August 2, 2017. http://dx.doi.org/10.1038/nature23305. - DOI - PubMed
-
- Orthwein A, Fradet-Turcotte A, Noordermeer SM, Canny MD, Brun CM, Strecker J, Escribano-Diaz C, Durocher D. Science. 2014;344:189–193. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources